Patent · US Active

Method to control tumor progression and invasiveness

US7569668B2 · kind B2 · utility

0Cited by

1References

1Claims

0Family size

Assignees

VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW · BE
UNIVERSITEIT GENT · BE

Inventors

Frans Van Roy · Laarne, BE
Geert Berx · Tienen, BE
Kristin STRUMANE · Amsterdam, NL

Key dates

Filing date	Jun 16, 2006
Grant date	Aug 4, 2009
Priority date	—
Expiry date	Sep 14, 2026

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/705
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is a method of modulating E-cadherin mediated cell adhesion. More specifically, described is the use of hECRep1a and homologues thereof to modulate and/or control tumor cell invasiveness.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.